Viruses

Companies Viruses

SIRION BIOTECH GmbH, Germany

SIRION BIOTECH is a technology leader in the field of functional gene analysis and cell models for basic research, drug and compound development. The company serves leading European and Japanese Drug and Biotech companies as a provider of latest technologies for them to advance identification of nov more

Products Viruses

ELISA kits for the measurment of SDF-1/CXCL12

SDF-1α (CXCL12) is a CXC chemokine. The small basic protein (ca. 8 kDa) has no glycosylation site in its sequence. The homology properties of SDF-1α are unique among the chemokines more

HIV Blot 2.2 Western Blot Assay - HIV Confirmation Test

HIV Blot 2.2 is an enzyme immunoassay for the in-vitro detection of antibodies to HIV in human serum or plasma. It is intended as a specific confirmation test. more

News Viruses

• Predicting risky sexual behavior

  A recent study by a team of researchers at the University of Nevada, Las Vegas found that risky sexual behavior can be predicted by cultural, socioeconomic and individual mores in conjunction with how one views themselves. Katherine Hertlein of the University of Nevada, Las Vegas will present her te more

• Plate reader for drug discovery
  

  The trend towards automated high content assays, particularly for systems biology and drug discovery, has stimulated the development of automated fluorescence microscopy systems to image sample arrays. Today’s commercially available high content analysis (HCA) instruments predominantly employ fluore more

• Tactics of new Middle East virus suggest treating by altering lung cells' response to infection
  

  A new virus that causes severe breathing distress and kidney failure elicits a distinctive airway cell response to allow it to multiply. Scientists studying the Human Coronavirus-Erasmus Medical Center, which first appeared April 2012 in the Middle East, have discovered helpful details about its str more

White papers Viruses

• Transfecting Mouse Fibroblast NIH 3T3 Cells with Lipid Reagents - A Comparative Study
  

  Prior to the advent of transfection lipids, mouse fibroblast NIH 3T3 cells were essentially untransfectable and other methods such as retroviral gene delivery had to be employed to circumvent this problem. Although retroviruses can be used for transgene expression in 100% of cells, the expression is often low. Additionally, NIH 3T3 cells are traditionally used for cellular transformation studies, and creating oncogenic retroviruses is not ideal due to bio-safety concerns. Recently, lentivruses have been used for high gene expression in cells (up to 100%). However, this method causes even greater bio-safety concerns and requires updating culture facilities to bio-safety level 2+, resulting in a costly and time-consuming procedure. more

• Real-Time PCR Quantification of Plant miRNAs Using Universal ProbeLibrary Technology
  

  MicroRNAs (miRNAs) are naturally occurring, highly conserved families of transcripts (18-25 nt in length) that are processed from larger hairpin precursors. Both plant and animal genomes encode miRNAs, and to date, there are over 4000 mature miRNA transcripts annotated. Although miRNAs represent a relatively abundant class of transcripts, their expression levels vary greatly among species and tissues. Less abundant miRNAs routinely fail detection using technologies such as cloning, northern hybridization and microarray analysis. Here, we present a real-time quantification method for accurate, sensitive, and economical detection of plant miRNAs based upon the stem-loop RT primer approach using an miRNA-specific primer coupled with a stem-loop specific Universal ProbeLibrary (UPL) probe. This approach represents a highly specific, sensitive, and easy-to-apply system to detect miRNAs. more

• New GS FLX Titanium Series Paired End Sequencing Improved De Novo Sequencing for High Quality Genome Assembly
  

  Roche Applied Science has launched the latest update to the Genome Sequencer FLX System, the new GS FLX Titanium Library Paired End Adaptors for improved whole genome de novo sequencing. Widely recognized as the platform of choice for de novo sequencing applications, as a result of the system's long shotgun reads, the addition of 3kb, 8 kb and 20 kb span paired end libraries now facilitates assembly of increasingly complex genomes. The improved sequencing solution offers biologists more complete genome coverage, assembly into fewer, larger scaffolds and the ability to explore the full range of genetic variation more

Publications Viruses

• [Report] Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization

  An algorithm predicts the neutralization specificity of sera from HIV-infected individuals. [Also see Perspective by Crowe] more

• [News & Analysis] Aids Research: More Woes for Struggling HIV Vaccine Field

  Devastating results from two trials have sent researchers scrambling—again. more

• [Research Article] Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

  Structural knowledge of broadly neutralizing antibodies against HIV-1 guides the design of an immunogen to elicit them. more

Market studies Viruses

• HIV / AIDS – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2012', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information on the therapeutic development for HIV / AIDS, complete with latest updates, and special features on late-stage and discontin more

• HIV-AIDS Testing Markets

  There are an estimated 33.3 million people living with HIV (the virus which causes AIDS) worldwide and approximately 2.6 million people are newly-infected each year. While the Asian and African regions account for more than 90% of the HIV-infected population (with the highest number in Sub-Saharan A more

• iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

  iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

Websites Viruses